Patents/Assignees

Mitenyi Biotec B.V. & Co. Kg

1 patent in portfolio

US12576148utility2026
Engineered Immune Effector Cells for Cancer Immunotherapy That Are Resistant to Fratricide by Virtue of Having Genetically Modified Surface Antigens
0 cites